Samalin Investment Counsel, LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 287 filers reported holding GW PHARMACEUTICALS PLC in Q1 2020. The put-call ratio across all filers is 1.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
Samalin Investment Counsel, LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q4 2020$237,000
+18.5%
2,0500.0%0.18%0.0%
Q3 2020$200,000
-1.5%
2,050
+23.7%
0.18%
-16.4%
Q2 2020$203,000
+24.5%
1,657
+5.9%
0.21%
+55.5%
Q4 2019$163,0001,5650.14%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2020
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders